![Amy Chappell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 105 $ al 30/09/2026
Amy S.
Chappell is currently an Independent Director at BioVie, Inc. since 2025 and Chief Medical Officer at Solaxa, Inc. since 2024.
Formerly, Dr. Chappell was Chief Medical Officer at Climb Bio, Inc. from 2020 to 2021.
Education includes undergraduate studies at Antioch College and a doctorate from The Indiana University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOVIE INC. CLASS A 0,01 % | 31/08/2026 | 727 ( 0,01 % ) | 1 105 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOVIE INC. | Director/Miembro de la Junta | 22/07/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| CLIMB BIO, INC. | Director Técnico/Científico/I+D | 31/12/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
BioVie, Inc.
 BioVie, Inc. BiotechnologyHealth Technology Develops drug therapies for chronic debilitating conditions | Health Technology |
Antioch College
 Antioch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
